Clinical-radiomics nomogram for predicting esophagogastric variceal bleeding risk noninvasively in patients with cirrhosis

Figure 6 The clinical decision curves for bleeding prediction. A: The training cohort; B: The validation cohort. A threshold probability is the point at which the expected benefits of a treatment equal those of not receiving treatment. As shown by the different lines in the diagram, red indicates the clinical-radiomics nomogram, green indicates Fibrosis-4 scores (FIB-4), yellow indicates Ratio of aspartate aminotransferase to platelets (APRI), pink indicates the hypothesis of patients without esophagogastric variceal bleeding (EGVB), and blue indicates that all patients developed EGVB. They indicate that the clinical-radiomics nomogram is superior to the non-invasive serum predictive model’s APRI and FIB-4 in terms of clinical utility. APRI: Ratio of aspartate aminotransferase to platelets; FIB-4: Fibrosis-4 scores.